SMSergey V. Medvedev

Sergey V. Medvedev

*This is an algorithmically generated author record based on publicly available information.

Sergey V. Medvedev has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Ultrahypofractionation in the treatment of disseminated skin melanoma patients with multiple brain metastases

    by S.V. Medvedev, E.V. Khmelevsky, E.D. Maslov, Yu.B. Karagodina, S.A. Kisaryev, S.E. Markov, S.A. Lapina, P.S. Toporov

    Objective. To improve local treatment efficacy and reduce neurological mortality in patients with multiple intracranial melanoma metastases using extreme hypofractionation of the whole-brain irradiation dose. Material and methods. The study included 45 patients with multiple melanoma metastases to the brain. Patients were divided into 2 groups. Group 1 (study group) received treatment with WBRT with a total dose of 6.5 Gy, 3 times weekly, with a total dose of 26 Gy. Twenty-four patients were treated. Group 2 (control group) received treatment according to clinical guidelines with WBRT with a total dose of 3 Gy, daily, with a total dose of 30 Gy. Twenty-one patients were treated. Results. Median survival was not statistically significantly different: 4.500 months in the study group versus 4.017 months in the control group, p=0.3436. The immediate effectiveness of therapy is demonstrated by better local control in the study group with a decrease in the average total volume of foci (p=0.0199) from 19.8 cm3 to 10.65 cm3 (by 46.21%), the average number of foci (p=0.0481) from 18.26 to 14.95 (18.13%) during the control study after 2 months, against a decrease in the average total volume of foci from 21.83 cm3 to 20.14 cm3 (by 7.32%), the average number of foci from 38.38 to 47.92 (an increase of 19.9%) during the standard treatment regimen. Effectiveness was also noted in improving the mean prognosis on the GPA scale from 0.913 before radiation therapy to 1.421 (a 35.75% improvement) in the study group, compared to an 11% improvement from 0.7188 before radiation therapy to 0.8077 (p=0.0144). Conclusion. Further study of the investigated method is required to confirm the efficacy and safety of this fractionation regimen in the treatment of patients with multiple intracranial melanoma metastases.

  • Organic Berry Production

    by Sergey Medvedev, Aleksander Semenov, Elena Semenova

  • Organic Gardening

    by Sergey Medvedev, Aleskander Semenov, Elena Semenova

  • Palliative radiotherapy for multiple brain metastases in skin melanoma

    by S.V. Medvedev, E.V. Khmelevskiy, E.D. Maslov, V.V. Boldyreva, S.A. Lapina, P.S. Toporov, P.N. Gashimova

    Melanoma is a malignant skin pathology, the treatment of which, in case of resistance to drug treatment, is a challenge for oncologists. Having a number of morphological and radiobiological features, melanoma manifests itself as a disease sensitive to radiation therapy, especially, to hypofractional regimens. We present a literature review and a clinical case of treating a patient with multiple brain melanoma metastases, progressing on drug treatment. However, after radiation therapy, we achieved a pronounced therapeutic effect, with a significant increase in life expectancy.

  • Open Access

    Expert Consensus on the Use of Hypofractionated Radiotherapy for Brain, Head and Neck, Breast, Colorectal, and Prostate Cancer. White Nights 2025

    by Сергей Николаевич Новиков, Ирина Александровна Акулова, Елена Рэмовна Ветлова, Артем Рубенович Геворков, Андрей Владимирович Голанов, Константин Борисович Гордон, Павел Владимирович Даценко, Тимур Раисович Измайлов, Сергей Васильевич Медведев, Наталья Юрьевна Некласова, et al.

    В статье представлены результаты голосования консенсуса экспертов по использованию режимов гипофракционирования дозы у больных со злокачественными новообразованиями различных локализаций, посвященного наиболее актуальным и спорным вопросам лучевого лечения опухолей головного мозга, головы и шеи, рака молочной железы, прямой кишки и предстательной железы. В консенсусе приняли участие 46 ведущих экспертов в области лучевой терапии злокачественных новообразований различных локализаций, проголосовавшие в ходе прямого эфира по 14 вопросам, разделенным на пять блоков. Учитывая возможность использования результатов экспертного голосования при составлении клинических рекомендаций, консенсус считался достигнутым только при 70 %-ном и более совпадении голосов.

  • Import substitution for planting material and fruit and berry products

    by E. I. Semenova, A. V. Semenov, S. M. Medvedev

    In this article, we assess the demand for and volumes of imported planting material in the Russian Federation. Changes in the composition of exporting countries supplying planting material and fruits to Russia have been revealed, including a shift from the import of saplings to the import of rootstocks and cuttings. In 2022 and 2024, the share of imported planting material amounted to 61 and 64.2 %, respectively. In 2022, according to consolidated financial statements, 39 % of the planting material used for orchard establishment was domestically produced. Businesses recognize the advantages and disadvantages of importing planting material; however, they have not abandoned this practice. Imports of fruits and berries were characterized by a decline in volumes by 2015 and a slight increase by 2024, alongside a steady decrease in volumes for commodity group 0808 (“Apples, pears, and quinces, fresh”). The increase in the production of fruits and berries is driven by the implementation of investment projects in this industrial sector, government support for the development of horticulture, and the introduction of an embargo on the import of foreign fruits and berries.

  • Open Access

    A clinical case of treatment of recurrent inoperable locally advanced breast cancer using conformal radiotherapy. Case report

    by Sergey V. Medvedev, Maria Yu. Vlasova, Larisa V. Bolotina, Andrey D. Kaprin, Evgeny V. Khmelevskiy, Aziz D. Zikiryakhodzhaev, Shakhnoz G. Khakimova, Gulnoz G. Khakimova, Natalya M. Bychkova, Natalia A. Zaitseva, et al.

    Despite advances in the early diagnosis of breast cancer (BC), the identification of locally advanced forms continues to be relevant. This is a complex category of patients whose treatment includes the complex use of various methods with significant medical and economic costs, long-term treatment and rehabilitation. A particular difficulty is the treatment in cases of progression of locally advanced forms. Patients with locally advanced BC require a multidisciplinary approach. In the absence of an effect after neoadjuvant drug treatment and the impossibility of performing surgical intervention, patients are treated with induction radiation therapy. The article describes the features of induction radiation therapy in the treatment of progression of primary inoperable BC in a specific clinical example. In case of recurrence of triple negative type of BC, the patient underwent various drug treatment regimens with the inclusion of immunotherapy. Due to the lack of effect from 3 lines of systemic drug treatment, it was decided to conduct radiation therapy. In connection with the identified carrier of a mutation in the BRCA1 gene, targeted therapy with PARP inhibitors was prescribed. Two months after radiation therapy and 1 month after the start of targeted therapy, the patient showed complete resorption of the tumor conglomerate on the anterior chest wall. The use of conformal radiation therapy in case of recurrence of the disease and the absence of the effect of systemic treatment made it possible to completely resorb an exophytic tumor with ulceration and achieve remission within the next 6 months.

  • Hypofractionate radiotherapy for a rare malignant neoplasm of epidermal origin — keratoacanthoma of the skin

    by S.V. Medvedev, E.V. Khmelevsky, A.D. Kaprin, E.A. Troshenkov, E.R. Abusheva, M.YU. Vlasova, E.D. Maslov, S.E. Markov, P.N. Gashimova, S.D. Guseva, et al.

    Keratoacanthoma is a rare malignant skin pathology. Having a number of morphological features, keratoacanthoma is a unique malignant neoplasm of epidermal origin. As a rule, externally, it is a formation with clearly delineated sloping edges and a characteristic crater-shaped depression in the center, filled with keratinous masses. Surgical resection is the gold standard treatment for keratoacanthoma, but treatment options for patients with persistent recurrence after surgical treatment are limited. We present the most comprehensive review of the literature on radiation therapy for postoperative and self-treatment of keratoacanthoma.

  • Efficiency of hypofractionated radiotherapy for bone metastases in a female patient with advanced skin melanoma

    by S.V. Medvedev, N.M. Bychkova, E.V. Khmelevsky

    Метастатическое поражение костей при меланоме кожи является частой локализацией диссеминации опухолевого процесса и встречается в 45% случаев, приводит к существенному снижению качества жизни за счет выраженного болевого синдрома. Вследствие исторического восприятия меланомы кожи как высокорадиорезистентной опухоли некоторые онкологи даже сейчас выступают против проведения лучевой терапии при этой патологии. Однако репутация меланомы как опухоли, нечувствительной к радиотерапии, не подтвердилась при гипофракционировании дозы лучевой терапии.

  • Open Access

    Difficulties associated with differential diagnosis between brain metastases and foci of necrosis resulted from stereotactic radiotherapy (case report and literature review)

    by А. V. Nazarenko, Т. N. Borisova, S. V. Medvedev, S. I. Tkachev, Е. А. Kobyakova, E. А. Nechipay, D. S. Romanov, N. А. Kozlov, D. V. Sashin, А. Kh. Bekyashev, et al.

    Modern advances in oncology can achieve significantly better results in terms of life expectancy in patients with metastatic brain disease. The combination of surgery, systemic therapy, whole brain irradiation and local methods of radiation therapy lead to good indicators for controlling the manifestations of the disease in the brain. Of course, intensification of treatment increases the risk of iatrogenic complications. The use of aggressive stereotactic radiotherapy regimens leads not only to high local control of irradiated metastases, but also to the risk of so-called radiation necrosis. The use of the most up-to-date diagnostic methods does not always allow one to unequivocally differentiate radiation necrosis from continued metastasis growth. The above example shows the need for a careful assessment of such situations and a multidisciplinary approach to interpreting the results of stereotactic radiotherapy.